Company profile: Novadip Biosciences
1.1 - Company Overview
Company description
- Provider of adipose stem cell-based therapies via the 3M3 tissue regeneration platform for hard and soft tissue reconstruction. Products include NVD-003 autologous therapy for critical-size bone reconstruction (CPT), NVD-X3 off-the-shelf allogeneic for bone non-union and spinal fusion, preclinical NVD-M2 for solid tumors, and miRNA/exosome therapeutics for systemic tissue diseases.
Products and services
- 3M3 Tissue Regeneration Platform: A three-dimensional extracellular matrix system using adipose-derived stem cells to generate growth factors and miRNAs for hard and soft tissue regeneration
- NVD-003: An autologous cell-based therapy for critical size bone reconstruction, particularly congenital pseudarthrosis of the tibia, using differentiated stem cells within an extracellular matrix delivering growth factors and miRNAs
- NVD-X3: An off-the-shelf allogeneic product engineered for accelerated, durable bone formation in non-union and spinal fusion, leveraging a matrix with bioactive factors to drive bone formation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Novadip Biosciences
Boston Orthotics & Prosthetics
HQ: United States
Website
- Description: Provider of paediatric orthotic and prosthetic patient care for medical professionals and patients, offering scoliosis solutions including Boston Brace 3D, Boston Brace Original, Boston Brace Night Shift, and Boston Brace RC, as well as Dynamic Movement Orthoses (DMO) and custom lower limb orthotics for children.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boston Orthotics & Prosthetics company profile →
FX Solutions
HQ: France
Website
- Description: Provider of shoulder prosthetic implants and instruments for orthopedic surgery. Designs and distributes stemless, reverse and invertible shoulder prostheses with hydroxyapatite coating for immediate fixation and long-term stability, featuring options like peripheral pegs, distal locking screws and short humeral stems, addressing trauma and osteoarthritis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FX Solutions company profile →
SafeWire
HQ: United States
Website
- Description: Provider of minimally invasive surgical instruments for spine procedures. Offers the Y-Wire with a patented design to reduce guidewire-related complications such as inadvertent advancement through bone, accidental pullout, kinking, and wire migration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SafeWire company profile →
Lifeward
HQ: United States
Website
- Description: Provider of wearable robotic exoskeletons and rehabilitation technologies for lower limb disabilities, including ReWalk Personal Exoskeleton for powered hip and knee motion to enable standing, walking, turning, and stair navigation; ReStore Exo-Suit for post-stroke gait training; AlterG Anti-Gravity treadmills to reduce gravitational load; and MYOLYN FES Cycling for therapeutic muscle building.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lifeward company profile →
CellRight Technologies
HQ: United States
Website
- Description: Provider of regenerative medicine solutions, developing osteoinductive and wound care scaffolds to improve healing of trauma- and disease-related defects. Offerings include dCELL soft tissue decellularization, BioRinse osteoinductive bone fillers, DermaPure dermal allografts, ConCelltrate bone grafts, AmnioWorks birth tissue barriers, and SurgiPure XD porcine xenografts. Serves Texas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CellRight Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Novadip Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Novadip Biosciences
2.2 - Growth funds investing in similar companies to Novadip Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Novadip Biosciences
4.2 - Public trading comparable groups for Novadip Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →